Of the 107 patients evaluated, 19 (male, n = 15; female, n = 4) had AML secondary to myelodysplastic syndrome (MDS); all but one was FLT3-ITD+, 14 had refractory disease and five had relapsed AML. Here, FLT3 is linked to myelodysplastic syndrome.